Shopping Cart
Remove All
Your shopping cart is currently empty
PROTACPD-L1 degrader-1 is a CRBN-based PD-L1-PROTAC degrader with significant PD-L1 protein degradation capacity. It demonstrates strong PD-L1 degradation activity in 4T1 cells, with a DC50 of 0.609 μM. This compound is applicable to breast cancer research.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Backorder | Backorder | |
| 50 mg | Inquiry | Backorder | Backorder |
| Description | PROTACPD-L1 degrader-1 is a CRBN-based PD-L1-PROTAC degrader with significant PD-L1 protein degradation capacity. It demonstrates strong PD-L1 degradation activity in 4T1 cells, with a DC50 of 0.609 μM. This compound is applicable to breast cancer research. |
| Targets&IC50 | Cereblon:131.77 μM (kd) |
| In vitro | PROTAC PD-L1 degrader-1 (compound PA8; 0.078-10 μM; 24 hours) significantly degrades PD-L1 protein in 4T1 cells in a dose-dependent manner. It exhibits specific binding to CRBN and PD-L1 with dissociation constant (K d) values of 131.77 μM and 59.2 μM, respectively, both showing concentration dependency. |
| In vivo | PROTAC PD-L1 degrader-18 (30-60 mg/kg; intraperitoneal injection; once daily for 15 days) effectively reduces both tumor volume and weight in a 4T1 tumor-bearing mouse model. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.